FR2422400A1 - Nouvelles compositions destinees a l'elimination de certains parasites humains, a base de lipoaminoacides, caracterises par des chaines grasses comportant de 6 a 12 atomes de carbone - Google Patents

Nouvelles compositions destinees a l'elimination de certains parasites humains, a base de lipoaminoacides, caracterises par des chaines grasses comportant de 6 a 12 atomes de carbone

Info

Publication number
FR2422400A1
FR2422400A1 FR7810857A FR7810857A FR2422400A1 FR 2422400 A1 FR2422400 A1 FR 2422400A1 FR 7810857 A FR7810857 A FR 7810857A FR 7810857 A FR7810857 A FR 7810857A FR 2422400 A1 FR2422400 A1 FR 2422400A1
Authority
FR
France
Prior art keywords
contg
aminoacid
compsns
acylated
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7810857A
Other languages
English (en)
Other versions
FR2422400B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7810857A priority Critical patent/FR2422400A1/fr
Publication of FR2422400A1 publication Critical patent/FR2422400A1/fr
Application granted granted Critical
Publication of FR2422400B1 publication Critical patent/FR2422400B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne la réalisation de nouvelles compositions destinées à la protection et à l'élimination de certains parasites humains, en particulier les peciculus capitis et corporis (poux), caractérisées en ce qu'elles contiennent des structures lipomonoaminoacides ou lipopolyaminoacides, ces dernières étant en présence ou non de ipopeptides; les céaines grasses acylées sur les acides aminés ou peptides comportant de 6 à 12 atomes de carbone.
FR7810857A 1978-04-13 1978-04-13 Nouvelles compositions destinees a l'elimination de certains parasites humains, a base de lipoaminoacides, caracterises par des chaines grasses comportant de 6 a 12 atomes de carbone Granted FR2422400A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7810857A FR2422400A1 (fr) 1978-04-13 1978-04-13 Nouvelles compositions destinees a l'elimination de certains parasites humains, a base de lipoaminoacides, caracterises par des chaines grasses comportant de 6 a 12 atomes de carbone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7810857A FR2422400A1 (fr) 1978-04-13 1978-04-13 Nouvelles compositions destinees a l'elimination de certains parasites humains, a base de lipoaminoacides, caracterises par des chaines grasses comportant de 6 a 12 atomes de carbone

Publications (2)

Publication Number Publication Date
FR2422400A1 true FR2422400A1 (fr) 1979-11-09
FR2422400B1 FR2422400B1 (fr) 1981-07-10

Family

ID=9207054

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7810857A Granted FR2422400A1 (fr) 1978-04-13 1978-04-13 Nouvelles compositions destinees a l'elimination de certains parasites humains, a base de lipoaminoacides, caracterises par des chaines grasses comportant de 6 a 12 atomes de carbone

Country Status (1)

Country Link
FR (1) FR2422400A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001131A1 (fr) * 1980-10-03 1982-04-15 Jolles P Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
EP0130644A1 (fr) * 1983-06-30 1985-01-09 Continental Pharma, Inc. Utilisation de l'acide 2-pentanoylaminoacétique et de ses sels
FR2609998A1 (fr) * 1987-01-26 1988-07-29 Morelle Jean Nouvelles substances antioxydantes derivees d'acides amines
EP0432039A2 (fr) * 1989-12-05 1991-06-12 NIPPON OILS & FATS CO., LTD. Médicament antipsychotique renferment un acyl-aminoacide
FR2675015A1 (fr) * 1991-04-12 1992-10-16 Astruc Jean Compositions destinees a la protection et a l'elimination des parasites humains, en particulier pediculus capitis et corporis, comportant des acetylpolyaminoacides, des extraits de ginkgo biloba et de propolis.
WO1992020647A1 (fr) * 1991-05-22 1992-11-26 Givaudan-Lavirotte Lipoaminoacides, leur procede de preparation et leurs applications
FR2698869A1 (fr) * 1992-12-09 1994-06-10 Morelle Jean Acylaminoacides obtenus à partir de fibres issues du Bombyx Mori.
WO2010084052A3 (fr) * 2009-01-22 2011-03-24 Laboratorios Miret, S. A. Utilisation de tensioactifs cationiques comme agents acaricides

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6475M (fr) * 1967-05-31 1968-11-18
FR2035751A6 (en) * 1969-02-10 1970-12-24 Morelle Jean Acylated amino acids for treating skin dis- - ease in animals
US3624114A (en) * 1969-12-18 1971-11-30 Jean V Morelle Fatty acid amido-methionine products
FR2224169A1 (en) * 1973-04-04 1974-10-31 Astruc Jean Antimicrobial fatty acid/amino acid compounds - for use against microorganisms (bacteria, fungi, viruses) in humans, animals and plants

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6475M (fr) * 1967-05-31 1968-11-18
FR2035751A6 (en) * 1969-02-10 1970-12-24 Morelle Jean Acylated amino acids for treating skin dis- - ease in animals
US3624114A (en) * 1969-12-18 1971-11-30 Jean V Morelle Fatty acid amido-methionine products
FR2224169A1 (en) * 1973-04-04 1974-10-31 Astruc Jean Antimicrobial fatty acid/amino acid compounds - for use against microorganisms (bacteria, fungi, viruses) in humans, animals and plants

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001131A1 (fr) * 1980-10-03 1982-04-15 Jolles P Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
EP0130644A1 (fr) * 1983-06-30 1985-01-09 Continental Pharma, Inc. Utilisation de l'acide 2-pentanoylaminoacétique et de ses sels
US4562205A (en) * 1983-06-30 1985-12-31 Continental Pharma Inc. Derivatives of 2-aminoacetic acid
FR2609998A1 (fr) * 1987-01-26 1988-07-29 Morelle Jean Nouvelles substances antioxydantes derivees d'acides amines
EP0432039A2 (fr) * 1989-12-05 1991-06-12 NIPPON OILS & FATS CO., LTD. Médicament antipsychotique renferment un acyl-aminoacide
EP0432039A3 (en) * 1989-12-05 1992-03-04 Nippon Oils & Fats Co., Ltd. Antipsychotic drug comprising an acylaminoacid
FR2675015A1 (fr) * 1991-04-12 1992-10-16 Astruc Jean Compositions destinees a la protection et a l'elimination des parasites humains, en particulier pediculus capitis et corporis, comportant des acetylpolyaminoacides, des extraits de ginkgo biloba et de propolis.
WO1992020647A1 (fr) * 1991-05-22 1992-11-26 Givaudan-Lavirotte Lipoaminoacides, leur procede de preparation et leurs applications
FR2698869A1 (fr) * 1992-12-09 1994-06-10 Morelle Jean Acylaminoacides obtenus à partir de fibres issues du Bombyx Mori.
EP0601911A1 (fr) * 1992-12-09 1994-06-15 Laboratoires Phytocos Acylaminoacides obtenus par l'acylation d'hydrolysats de protéines et compositions anti-microbiennes, antiparasitaires ou cosmétiques en contenant
WO2010084052A3 (fr) * 2009-01-22 2011-03-24 Laboratorios Miret, S. A. Utilisation de tensioactifs cationiques comme agents acaricides

Also Published As

Publication number Publication date
FR2422400B1 (fr) 1981-07-10

Similar Documents

Publication Publication Date Title
FI934330A (fi) Xylanas, motsvarande rekombinant-dna-sekvens, ett innehaollande xylanassamt anvaendning av medlet
EP0871654A4 (fr) Protegrines
ES2061435T3 (es) Procedimiento y agentes para la inhibicion del envejecimiento de las proteinas.
AU2867089A (en) (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active ingredient
ATE135208T1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
FR2422400A1 (fr) Nouvelles compositions destinees a l'elimination de certains parasites humains, a base de lipoaminoacides, caracterises par des chaines grasses comportant de 6 a 12 atomes de carbone
CA2083595A1 (fr) Methode d'induction des mecanismes de defense d'une plante
ATE99281T1 (de) Verfahren zur herstellung von 7-substituierten hept-6-en- und heptansaeuren und derivaten davon.
KR890001475A (ko) 반죽제품 변성 방지제
KR870000356A (ko) 메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
ATE19884T1 (de) Verfahren zur herstellung von phosphonomethylierten aminosaeuren.
PT91776A (pt) Processo para a preparacao de peptolidos contendo acido pipecolico e composicoes farmaceuticas que os contem
DE3879429D1 (de) Cyclopropanderivate.
JPS56501648A (fr)
DE69001107D1 (de) Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen.
ATE174220T1 (de) Verwendung von leflunomid zur hemmung von interleukin 8
ATA113089A (de) Pharmazeutisches praeparat zur behandlung von lebererkrankungen
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
ATE87906T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
ES2045092T3 (es) Un procedimiento de manufactura de un producto farmaceutico para tratamiento de cancer.
FR2675667B1 (fr) Agent edulcorant derivant a l'acide l-aspartique ou l-glutamique; son procede de preparation.
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
US3674833A (en) Salts of ethyl o-(cyclohexylamino-alkanoylamino)-benzoate

Legal Events

Date Code Title Description
ST Notification of lapse